| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 3e-11 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.28 | 9e-08 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |